Can targeting of IL-6 lead to CV protection in CKD?

5' education - May 19, 2021 - Prof. Paul Ridker, MD - Boston, MA, USA

Educational information

This video was recorded during the virtual congress of the ACC.21.

Faculty

Dr. Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of this trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.